Search - tctmd.com

Displaying 1 - 20 of 36

Sort: Relevancy | Date

News Daily News

Deferred PCI Equally Safe When Decision-making’s Based on IVUS vs FFR

Caitlin E. Cox

December 07, 2023

News Conference News LINC 2023

PROSPECT MONSTER: Real-World Data Confirm Low-Dose DCB Efficacy in PAD

L.A. McKeown

June 21, 2023

News Conference News ACC 2023

Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III

Shelley Wood

March 04, 2023

News Daily News

Cardiac Imaging’s Carbon Footprint: Time for Awareness and Action

Yael L. Maxwell

December 16, 2022

News Conference News ESC 2022

Routine Functional Testing Unnecessary After Stenting: POST-PCI

Yael L. Maxwell

September 06, 2022

News Conference News EuroPCR 2022

Intravascular Imaging Boosts Outcomes in Left Main PCI: ROLEX

Michael O'Riordan

May 18, 2022

News Conference News ACC 2022

FLAVOUR: FFR as Good as IVUS for Intermediate Coronary Stenoses

Michael O'Riordan

April 06, 2022

News Opinion CV Team Dispatch

January 2022 News Roundup

L.A. McKeown

January 01, 2022

News Daily News

New Revascularization Guidelines Plug Radial Access, Staged PCI, and Shorter DAPT

Michael O'Riordan

December 09, 2021

News Daily News

Cardiac Deaths and Adverse Events After PCI Have Declined With Time

L.A. McKeown

October 05, 2021

News Conference News EuroPCR 2021

FUTURE II: A Good ‘First Step’ for Thinner-Strut Bioresorbable Scaffold

Michael O'Riordan

May 19, 2021

News Conference News TCT 2020

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

Michael O'Riordan

October 14, 2020

News Daily News

Revascularization After PCI or CABG Linked to Higher Mortality: EXCEL

Michael O'Riordan

January 17, 2020

News Conference News TCT 2019

IVUS-XPL at 5 Years Shows Durability of Imaging Guidance in PCI

Caitlin E. Cox

October 08, 2019

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Daily News

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

Michael O'Riordan

October 11, 2017

News Conference News ACC 2017

CARAT: Novel HDL Mimetic Fails to Show Benefit in Coronary Atherosclerosis After ACS

Yael L. Maxwell

March 18, 2017

News Daily News

New Laser-Based Imaging Modality in Development for Atherosclerosis Assessment

Todd Neale

February 17, 2017

News Features

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Shelley Wood

December 30, 2016

News Conference News AHA 2016

PCSK9 Inhibition and Other New Therapies for Lipid Modification: Good News and Bad

Michael O'Riordan

November 15, 2016

Advertisement

Deferred PCI Equally Safe When Decision-making’s Based on IVUS vs FFR

PROSPECT MONSTER: Real-World Data Confirm Low-Dose DCB Efficacy in PAD

Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III

Cardiac Imaging’s Carbon Footprint: Time for Awareness and Action

Routine Functional Testing Unnecessary After Stenting: POST-PCI

Intravascular Imaging Boosts Outcomes in Left Main PCI: ROLEX

FLAVOUR: FFR as Good as IVUS for Intermediate Coronary Stenoses

January 2022 News Roundup

New Revascularization Guidelines Plug Radial Access, Staged PCI, and Shorter DAPT

Cardiac Deaths and Adverse Events After PCI Have Declined With Time

FUTURE II: A Good ‘First Step’ for Thinner-Strut Bioresorbable Scaffold

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

Revascularization After PCI or CABG Linked to Higher Mortality: EXCEL

IVUS-XPL at 5 Years Shows Durability of Imaging Guidance in PCI

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

CARAT: Novel HDL Mimetic Fails to Show Benefit in Coronary Atherosclerosis After ACS

New Laser-Based Imaging Modality in Development for Atherosclerosis Assessment

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

PCSK9 Inhibition and Other New Therapies for Lipid Modification: Good News and Bad

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content